GB0021055D0 - Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes - Google Patents

Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes

Info

Publication number
GB0021055D0
GB0021055D0 GB0021055A GB0021055A GB0021055D0 GB 0021055 D0 GB0021055 D0 GB 0021055D0 GB 0021055 A GB0021055 A GB 0021055A GB 0021055 A GB0021055 A GB 0021055A GB 0021055 D0 GB0021055 D0 GB 0021055D0
Authority
GB
United Kingdom
Prior art keywords
diabetes
espicially
disease
condition associated
metabolic disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0021055A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0021055A priority Critical patent/GB0021055D0/en
Priority to ARP000104821A priority patent/AR028299A1/en
Priority to CO00069666A priority patent/CO5200844A1/en
Priority to SG200401291A priority patent/SG127714A1/en
Priority to TW092125226A priority patent/TWI278312B/en
Priority to EP00969260A priority patent/EP1212077A2/en
Priority to BR0014525-4A priority patent/BR0014525A/en
Priority to PE2000000955A priority patent/PE20010739A1/en
Priority to JP2001524585A priority patent/JP2003509457A/en
Priority to EP08167253A priority patent/EP2011507A2/en
Priority to IL14816800A priority patent/IL148168A0/en
Priority to HU0400932A priority patent/HUP0400932A3/en
Priority to CNB008019762A priority patent/CN1309380C/en
Priority to CZ20011723A priority patent/CZ20011723A3/en
Priority to MYPI20050152A priority patent/MY143051A/en
Priority to CN2007100789262A priority patent/CN101002758B/en
Priority to SK360-2002A priority patent/SK3602002A3/en
Priority to KR10-2002-7003551A priority patent/KR100506428B1/en
Priority to FR0011782A priority patent/FR2798592B1/en
Priority to NZ528738A priority patent/NZ528738A/en
Priority to MYPI20004314A priority patent/MY131810A/en
Priority to KR1020047010952A priority patent/KR100544244B1/en
Priority to AU79044/00A priority patent/AU7904400A/en
Priority to CA2381992A priority patent/CA2381992C/en
Priority to TW089118960A priority patent/TWI278311B/en
Priority to PL00354168A priority patent/PL354168A1/en
Priority to NZ517280A priority patent/NZ517280A/en
Priority to PCT/EP2000/009074 priority patent/WO2001021159A2/en
Priority to BE2000/0585A priority patent/BE1013726A5/en
Publication of GB0021055D0 publication Critical patent/GB0021055D0/en
Priority to ARP010100516A priority patent/AR028504A2/en
Priority to FI20010683A priority patent/FI20010683A/en
Priority to NO20021197A priority patent/NO20021197L/en
Priority to HK02107767.4A priority patent/HK1046101A1/en
Priority to US10/345,908 priority patent/US6878749B2/en
Priority to US11/036,842 priority patent/US20050124663A1/en
Priority to JP2006241423A priority patent/JP2006335767A/en
Priority to US11/781,630 priority patent/US20070275928A1/en
Priority to ARP090102868A priority patent/AR072329A2/en
Priority to US12/624,976 priority patent/US20100076084A1/en
Ceased legal-status Critical Current

Links

GB0021055A 1999-09-17 2000-08-26 Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes Ceased GB0021055D0 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
GB0021055A GB0021055D0 (en) 2000-08-26 2000-08-26 Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes
ARP000104821A AR028299A1 (en) 1999-09-17 2000-09-14 A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
CO00069666A CO5200844A1 (en) 1999-09-17 2000-09-14 A COMBINATION THAT INCLUDES NATEGLINED AND WHEN AT LEAST ANOTHER ANTI-DIABETIC COMPOUND USED FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR OF A DISEASE OR CONDITION ASSOCIATED WITH DIBETES
NZ528738A NZ528738A (en) 1999-09-17 2000-09-15 Composition comprising nateglinide for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
AU79044/00A AU7904400A (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
EP00969260A EP1212077A2 (en) 1999-09-17 2000-09-15 Pharmaceutical composition of nateglinide and another antidiabetic agent
BR0014525-4A BR0014525A (en) 1999-09-17 2000-09-15 Process of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
PE2000000955A PE20010739A1 (en) 1999-09-17 2000-09-15 COMBINATION OF NATEGLINIDE AND AN ANTIDIABETIC COMPOUND FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES
JP2001524585A JP2003509457A (en) 1999-09-17 2000-09-15 Methods for treating metabolic disorders, especially diabetes, or diabetes-related diseases or conditions
EP08167253A EP2011507A2 (en) 1999-09-17 2000-09-15 Pharmaceutical composition of nateglinide and another antidiabetic agent
IL14816800A IL148168A0 (en) 1999-09-17 2000-09-15 Pharmaceutical composition of nateglinide and another antidiabetic agent
KR1020047010952A KR100544244B1 (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
CNB008019762A CN1309380C (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
CZ20011723A CZ20011723A3 (en) 1999-09-17 2000-09-15 Combination containing nateglinide and pharmaceutical preparation in which this combination is comprised and which is intended for treating metabolic disorders, in particular diabetes and diseases and conditions associated therewith
MYPI20050152A MY143051A (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
CN2007100789262A CN101002758B (en) 1999-09-17 2000-09-15 Use of composition for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
TW092125226A TWI278312B (en) 1999-09-17 2000-09-15 Pharmaceutical composition for treating diabetes or a disease or condition associated with diabetes
KR10-2002-7003551A KR100506428B1 (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
FR0011782A FR2798592B1 (en) 1999-09-17 2000-09-15 METHOD OF TREATING MATABOLIC DISORDERS, IN PARTICULAR DIABETES, OR DISEASE OR DISORDER ASSOCIATED WITH DIABETES
SG200401291A SG127714A1 (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
MYPI20004314A MY131810A (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
HU0400932A HUP0400932A3 (en) 1999-09-17 2000-09-15 Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
SK360-2002A SK3602002A3 (en) 1999-09-17 2000-09-15 Combination containing nateglinide and pharmaceutical composition comprising said combination for treating metabolic disorders
BE2000/0585A BE1013726A5 (en) 1999-09-17 2000-09-15 Method for the treatment of metabolic disorders, especially diabetes or disease or condition associated with diabetes.
TW089118960A TWI278311B (en) 1999-09-17 2000-09-15 Combination for treating diabetes or a disease or condition associated with diabetes
PL00354168A PL354168A1 (en) 1999-09-17 2000-09-15 Pharmaceutical composition of nateglinide and another antidiabetcagent
NZ517280A NZ517280A (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
PCT/EP2000/009074 WO2001021159A2 (en) 1999-09-17 2000-09-15 Pharmaceutical composition of nateglinide and another antidiabetcagent
CA2381992A CA2381992C (en) 1999-09-17 2000-09-15 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
ARP010100516A AR028504A2 (en) 1999-09-17 2001-02-05 COMBINATION, METHOD FOR IMPROVING THE BODY APPEARANCE OF A MAMMER, PHARMACEUTICAL COMPOSITION, USE OF SUCH COMBINATION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTION, DELAY OF PROGRESS, OR TREATMENT OF METABOLIC DISORDERS, AND COMMERCIAL PACKAGE
FI20010683A FI20010683A (en) 1999-09-17 2001-04-02 Procedure for the treatment of metabolic disorders, especially diabetes or a disease or condition associated with diabetes
NO20021197A NO20021197L (en) 1999-09-17 2002-03-11 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
HK02107767.4A HK1046101A1 (en) 1999-09-17 2002-10-25 Pharmaceutical composition of nateglinide and another antidiabetic agent
US10/345,908 US6878749B2 (en) 1999-09-17 2003-01-16 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
US11/036,842 US20050124663A1 (en) 1999-09-17 2005-01-14 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
JP2006241423A JP2006335767A (en) 1999-09-17 2006-09-06 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
US11/781,630 US20070275928A1 (en) 1999-09-17 2007-07-23 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
ARP090102868A AR072329A2 (en) 1999-09-17 2009-07-28 PHARMACEUTICAL COMPOSITION THAT NATEGLINIDA UNDERSTANDS
US12/624,976 US20100076084A1 (en) 1999-09-17 2009-11-24 Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0021055A GB0021055D0 (en) 2000-08-26 2000-08-26 Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes

Publications (1)

Publication Number Publication Date
GB0021055D0 true GB0021055D0 (en) 2000-10-11

Family

ID=9898365

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0021055A Ceased GB0021055D0 (en) 1999-09-17 2000-08-26 Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes

Country Status (1)

Country Link
GB (1) GB0021055D0 (en)

Similar Documents

Publication Publication Date Title
NO20021197D0 (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
AU2002327430A8 (en) Methods for treating diabetes and other blood sugar disorders
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
AU2003241173A8 (en) 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
AU2001231104A1 (en) Methods for treating diabetes
AP2004003026A0 (en) Methods for treating ocular neovascular diseases.
MXPA03005155A (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism.
AU2002258428A1 (en) Methods for the treatment of metabolic disorders, including obesity and diabetes
AU2001227837A1 (en) Novel treatment for eye disease
HUP0002628A2 (en) Pharmaceutical combinations for treating diabetes
ZA200300418B (en) Method of treating cardiovascular disease.
HUP0204129A3 (en) Method for producing 1,2-dichloroethane
MXPA03000188A (en) Methods of treating neutrophil-related diseases with topical anesthetics.
AU2003296341A8 (en) System and method for treating Parkinson's Disease and other movement disorders
HUP0303442A3 (en) Method for producing mdi, especially 2,4'-mdi
ZA995444B (en) A method for the treatment of staphylococcal disease.
AP2003002834A0 (en) Method of treating of demyelinating disease or conditions.
AU2003252182A8 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
MXPA03006607A (en) Combined method for treating hormono-dependent disorders.
PL366168A1 (en) Impregnate, method for the production and use thereof
WO2002086504A3 (en) Individualization of therapy with gastroesophageal reflux disease agents
WO2002099422A3 (en) Individualization of therapy with alzheimer's disease agents
GB0021055D0 (en) Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes
ZA200309946B (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes.
ITMI20002019A0 (en) METHOD FOR TREATMENT OF METABOLIC DISORDERS, PARTICULARLY DIABETES OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)